Andere talen MOVANO INC COM USD0.0001

Index

MOVE

US62459M1071

Beurs gesloten - Nasdaq 22:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,424 ^PTS	-3,64%		-2,53%	-45,74%

15/05	Transcript : Movano Inc., Q1 2024 Earnings Call, May 15, 2024
09/05	Movano Health dient voorbeeldige Sp02 klinische onderzoeksresultaten in als belangrijke stap naar FDA 510(k) goedkeuringsbesluit	CI

Nieuws in andere talen over MOVANO INC COM USD0.0001

Earnings Flash (MOVE) MOVANO Reports Q1 Revenue $852,000	15/05
Movano Health Reports Q1 2024 Financial Results and Provides Business Update	15/05
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision	09/05
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision	09/05
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024	06/05
Movano Inc. announced that it has received $24.128792 million in funding	04/04
Movano Health Closes $24 Million Private Placement	08/04
Movano Health Closes $24 Million Private Placement	05/04
Movano Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	04/04
Movano Health Reports 2023 Financial Results and Provides Business Update	04/04
BestGrowthStocks.Com Issues Comprehensive Evaluation of Movano Inc.	03/04
Movano to Raise $24 Million From Share Placement	03/04
Movano Health Announces $24 Million Private Placement	02/04
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company	02/04
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024	02/04
Movano Inc. announced that it expects to receive $24.14411 million in funding	02/04
Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial	14/03
Movano Health's Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial	14/03
Certain Common Stock of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.	12/02
Certain Warrants of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.	12/02
Certain Options of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.	12/02
Movano Health Announces Evie Rings Now Shipping	22/01
Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women	09/01
Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level	08/01
Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring	18/12
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement	12/12
Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award	05/12
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement	29/11
Evie, the Smart Ring for Women from Movano Health, Available for Order Today	20/11
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option	17/11
Movano Insider Bought Shares Worth $250,750, According to a Recent SEC Filing	15/11
Movano Prices Common Stock Offering at $0.85 per Share	15/11
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results	15/11
Movano Health Prices $3.6 Million Public Offering	15/11
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023	14/11
Movano Health Announces Proposed Public Offering	14/11
Movano Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023	03/11
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring	31-10-23
Movano Health to Launch the Evie Ring on November 20	30-10-23
Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board	12-09-23
Movano Inc. Appoints Fátima Rodriguez to Its Medical Advisory Board	12-09-23
Certain Common Stock of Movano Inc. are subject to a Lock-Up Agreement Ending on 11-SEP-2023.	11-09-23
Certain Warrants of Movano Inc. are subject to a Lock-Up Agreement Ending on 11-SEP-2023.	11-09-23
Certain Options of Movano Inc. are subject to a Lock-Up Agreement Ending on 11-SEP-2023.	11-09-23

1 2 3 4

Headlines

Indexen - moeilijk jaarbegin voor aandelen in India en Brazilië

14 mei 2024 om 23:03 uur